• Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages

    来源: Buzz FX / 08 2月 2025 04:06:10   America/New_York


    Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Rating of "Moderate Buy" by Brokerages Written by MarketBeat February 8, 2025 Share Link copied to clipboard. Shares of Nektar Therapeutics ( NASDAQ:NKTR - Get Free Report ) have received an
    Read more...
分享